We read with interest the study by Katz and colleagues in a recent issue of Circulation. 1 The authors have measured exhaled NO and a key observation is that a low level of exhaled NO is associated with an increased mortality risk in patients with chronic heart failure. They claim that exhaled NO is a marker of endothelial function.
Response
I thank Drs Lundberg and Weitzberg for their interest in our recently published report. 1 Our technique for exhaled nitric oxide determination differs from many previous reports, as our measurements were made at a submaximal work rate adjusted to a minute ventilation of 20 L/min. In preliminary experiments, inhalation of aerosolized L-NG-monomethylarginine decreased exhaled nitric oxide production during submaximal exercise in normal subjects but not in subjects with chronic heart failure. These findings suggest that nasopharyngeal and upper airway sources of nitric oxide did not contaminate our measurements during submaximal exercise in heart failure subjects and are consistent with the findings of Philips and colleagues, 2 who showed that the effects of nasopharyngeal balloon occlusion on exhaled nitric oxide production were diminished during higher minute ventilation rates in response to exercise. We agree that nitric oxide in expired gases may be derived from cellular sources other than endothelial cells. As discussed in our article, 1 our finding of a significant association between exhaled nitric oxide production during submaximal exercise and mortality may be related to reduced endothelial production of nitric oxide in the pulmonary circulation, but may also be attributable to autonomic, hemodynamic, and pulmonary abnormalities present in this patient population.
